A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib
暂无分享,去创建一个
Martin C. Müller | D. Niederwieser | K. Porkka | I. Mikkola | A. Hochhaus | T. Ernst | T. Lange | F. Gruber | M. Pfirrmann | O. Pelz-Ackermann | J. Maier